OverviewChartTechnicalNewsTraderScreen

Corbus Pharmaceuticals Holdings I.../  US21833P3010  /

NASDAQ
2024-05-21  7:08:49 PM Chg. -2.5750 Volume Bid2024-05-21 Ask2024-05-21 High Low
45.9750USD -5.30% 156,525
Turnover: 5.91 mill.		 45.6900Bid Size: 200 46.2600Ask Size: 400 50.4200 45.5000
GlobeNewswire 05-09 Corbus Pharmaceuticals to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
GlobeNewswire 05-07 Corbus Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 05-01 Corbus Pharmaceuticals to Participate in the BTIG Obesity Health Forum
GlobeNewswire 04-24 Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO Annual Meeting
GlobeNewswire 04-02 Corbus Announces Dosing of First Patient in U.S. Phase 1 Clinical Trial of Its Next Generation Necti...
GlobeNewswire 03-12 Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corpo...
GlobeNewswire 03-06 Corbus Pharmaceuticals to Participate in the BMO Capital Markets Inaugural Obesity Summit
GlobeNewswire 02-28 Corbus Pharmaceuticals Appoints Dr. Dominic Smethurst as Chief Medical Officer
GlobeNewswire 02-06 Corbus Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
GlobeNewswire 02-02 Corbus Pharmaceuticals Announces Closing of $94.5 Million Public Offering of Common Stock including ...
GlobeNewswire 01-31 Corbus Pharmaceuticals Announces Pricing of Public Offering
GlobeNewswire 01-31 Corbus Pharmaceuticals Announces Proposed Public Offering
GlobeNewswire 01-26 CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting Antibody Drug Conjugate Demonstrates Encourag...
GlobeNewswire 01-23 Phase 1 Clinical Data for SYS6002 (CRB-701) to be presented at 2024 ASCO GU
GlobeNewswire 01-09 Corbus Pharmaceuticals Announces FDA Clearance of IND Application for its anti-αvβ8 monoclonal antib...
GlobeNewswire 2023-12-18 Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO GU
GlobeNewswire 2023-11-07 Corbus Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire 2023-11-02 Corbus Pharmaceuticals Presents Results of Two Pre-Clinical Studies on its Anti-αVβ8 Monoclonal Anti...
GlobeNewswire 2023-10-17 Corbus Pharmaceuticals Announces Publication of Data for its Novel Cannabinoid Type-1 Receptor Inver...
GlobeNewswire 2023-10-16 Corbus Pharmaceuticals Presents the First Pre-Clinical Characterization of its Next Generation Necti...
GlobeNewswire 2023-10-03 Corbus Pharmaceuticals to Host Virtual ‘Meet the Expert’ Series (Session 2) on CRB-701 on October 10...
GlobeNewswire 2021-08-12 Corbus Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Updates
GlobeNewswire 2021-06-24 Corbus Pharmaceuticals Announces Topline Results from DETERMINE Phase 3 Study of Lenabasum for Treat...
GlobeNewswire 2021-06-01 Corbus Pharmaceuticals Licenses Two Integrin Targeting mAbs Further Expanding Pipeline into Cancer a...
GlobeNewswire 2021-05-25 Corbus Pharmaceuticals Announces Publication of Two Abstracts at EULAR 2021 Virtual Congress